Pediatric Neurology in Germany

Paediatric neurology encompasses the diagnosis and management of neurological disorders arising in infancy, childhood, and adolescence. German university children's hospitals maintain dedicated neuropaediatric departments staffed by paediatric neurologists with subspecialty training in childhood neurological conditions, supported by paediatric neuroradiology, neurophysiology, neuropathology, and clinical genetics services. The multidisciplinary structure of German university paediatric neurology departments enables comprehensive evaluation and management of complex conditions including epileptic encephalopathies, neuromuscular disorders, metabolic brain diseases, and paediatric brain tumours. For international families seeking specialist evaluation of a child with a neurological condition, German paediatric neurologists provide structured assessment that addresses the accuracy of the diagnosis, the completeness of the diagnostic workup, and the appropriateness of the current management plan.

About the Condition

The spectrum of neurological conditions encountered in paediatric neurology is broad and includes conditions unique to childhood as well as paediatric presentations of conditions that also occur in adults. Epilepsy and epileptic encephalopathies — including Dravet syndrome, Lennox-Gastaut syndrome, West syndrome, and CDKL5 deficiency disorder — represent a major category of paediatric neurological disease, with genetic and structural aetiologies accounting for an increasing proportion of cases as next-generation sequencing becomes routine. Neuromuscular disorders including Duchenne muscular dystrophy, spinal muscular atrophy, and congenital myopathies require multidisciplinary management integrating neurology, respiratory medicine, cardiology, and rehabilitation. Cerebral palsy, the most common cause of physical disability in childhood, encompasses a spectrum of motor disorders arising from non-progressive brain injury or malformation occurring in the developing brain. Metabolic and genetic neurological diseases, including mitochondrial disorders, lysosomal storage diseases, and leukodystrophies, require specialised metabolic investigation and often have specific treatment implications.

Common Symptoms

• Developmental regression — loss of previously acquired motor, language, or cognitive milestones
• Seizures in infancy or childhood, including infantile spasms, absence seizures, and febrile seizures with atypical features
• Hypotonia — reduced muscle tone in infancy, presenting as a floppy infant with poor head control
• Progressive motor weakness or loss of ambulation in a previously walking child
• Abnormal gait, coordination difficulties, or ataxia developing in childhood
• Macrocephaly or microcephaly detected on routine measurement or parental concern
• Persistent or progressive headaches in a child, particularly those associated with vomiting or waking from sleep
• Cognitive or behavioural regression, school difficulties, or unexplained changes in personality

Causes and Risk Factors

Neurological conditions in children arise from a diverse range of genetic, structural, metabolic, infectious, immune, and acquired aetiologies. Genetic causes have become increasingly identifiable through next-generation sequencing, with single-gene disorders, chromosomal abnormalities, and copy number variants accounting for a substantial proportion of paediatric neurological disease. Structural brain abnormalities including cortical malformations, periventricular leukomalacia, and hypoxic-ischaemic encephalopathy arise from disruptions to normal brain development or injury during the perinatal period. Metabolic disorders including mitochondrial diseases, organic acidaemias, and aminoacidopathies affect neurological function through disruption of cellular energy metabolism or accumulation of toxic metabolites. Autoimmune encephalitides, including anti-NMDA receptor encephalitis, are an important and treatable cause of acute neurological deterioration in children. Infectious causes include bacterial and viral meningitis, encephalitis, and post-infectious immune-mediated conditions.

Diagnostic Process in Germany

Diagnostic evaluation in paediatric neurology at German university hospitals is tailored to the child's age, clinical presentation, and the suspected diagnostic category. MRI of the brain and spinal cord using paediatric-specific protocols — including sequences optimised for myelination assessment, cortical development, and metabolic disease — is the primary structural investigation. EEG with age-appropriate electrode placement and activation procedures is used for epilepsy evaluation, with long-term video-EEG monitoring available for complex cases. Nerve conduction studies and electromyography are adapted for paediatric patients to assess peripheral nerve and muscle function. Metabolic investigations including plasma amino acids, urine organic acids, lactate, ammonia, and lysosomal enzyme assays are performed where a metabolic aetiology is suspected. Genetic testing using next-generation sequencing panels, whole exome sequencing, or whole genome sequencing is increasingly used as a first-line investigation in children with unexplained neurological disease. Muscle and nerve biopsy with histopathological and electron microscopic analysis is performed where a neuromuscular diagnosis requires tissue confirmation.

Treatment Options in Germany

Treatment of neurological conditions in children at German university paediatric hospitals is guided by evidence-based protocols adapted to the specific diagnosis, the child's age, and the family's circumstances. Epilepsy management includes antiseizure medication selection guided by syndrome classification and genetic aetiology, with syndrome-specific drugs such as sodium valproate for generalised epilepsies, vigabatrin for infantile spasms, and stiripentol for Dravet syndrome. Disease-modifying therapies for neuromuscular disorders include nusinersen and onasemnogene abeparvovec for spinal muscular atrophy, and ataluren and exon-skipping therapies for Duchenne muscular dystrophy. Enzyme replacement therapy is available for lysosomal storage diseases including Gaucher disease, Fabry disease, and Pompe disease. Autoimmune encephalitides are treated with immunotherapy including corticosteroids, intravenous immunoglobulin, and rituximab. Multidisciplinary rehabilitation — integrating physiotherapy, occupational therapy, speech and language therapy, and educational support — is a core component of management for children with chronic neurological conditions.

• Syndrome-specific antiseizure medication therapy for paediatric epilepsy and epileptic encephalopathies
• Ketogenic diet therapy for drug-resistant epilepsy, including Dravet syndrome and Lennox-Gastaut syndrome
• Paediatric epilepsy surgery evaluation and resective procedures at accredited paediatric epilepsy centres
• Nusinersen (Spinraza) and onasemnogene abeparvovec (Zolgensma) for spinal muscular atrophy
• Exon-skipping therapy (ataluren, eteplirsen) for eligible Duchenne muscular dystrophy patients
• Enzyme replacement therapy for lysosomal storage diseases (Gaucher, Fabry, Pompe)
• Immunotherapy for autoimmune encephalitis (corticosteroids, IVIG, rituximab)
• Multidisciplinary neurorehabilitation including physiotherapy, occupational therapy, and speech therapy

Why Treatment in Germany

German university children's hospitals operate paediatric neurology departments with subspecialty expertise across the full range of childhood neurological conditions, including dedicated teams for paediatric epilepsy, neuromuscular disease, metabolic neurology, and paediatric neuro-oncology. The availability of advanced genetic diagnostic technologies — including whole exome and whole genome sequencing — within the university hospital framework enables rapid aetiological diagnosis in children with unexplained neurological disease. German paediatric neurologists participate in European paediatric neurology networks and clinical trial consortia, providing access to emerging therapies including gene therapies for neuromuscular disorders. The multidisciplinary structure of German university paediatric hospitals ensures that children with complex neurological conditions receive coordinated care from neurology, neurosurgery, genetics, metabolic medicine, rehabilitation, and educational support services.

Specialist Evaluation

A paediatric neurology evaluation at a German university hospital begins with a comprehensive review of the developmental history, neurological examination findings, neuroimaging, neurophysiological studies, metabolic investigations, and genetic results. The paediatric neurologist assesses the accuracy of the current diagnosis, identifies any gaps in the diagnostic workup, and determines whether the current management is appropriate for the specific condition and the child's developmental stage. For children with drug-resistant epilepsy, the evaluation addresses surgical candidacy and the completeness of the presurgical workup. For children with neuromuscular disorders, the evaluation assesses eligibility for disease-modifying therapies. The evaluation report provides a structured clinical opinion with specific recommendations for further investigation, treatment adjustment, and multidisciplinary support.

Patient Pathway

1. 1

   Submit developmental history, neurological examination reports, neuroimaging, EEG recordings, metabolic and genetic investigations, and current treatment documentation

2. 2

   Clinical coordinator reviews documentation and routes the case to the paediatric neurology subspecialty team

3. 3

   Paediatric neurologist reviews all available data, assesses diagnostic accuracy, and identifies any additional investigations required

4. 4

   Structured evaluation report prepared with diagnostic opinion, treatment recommendations, and eligibility assessment for specific therapies

5. 5

   Case directed to the relevant university hospital paediatric neurology department for formal consultation and treatment planning

6. 6

   Ongoing coordination of diagnostic workup, treatment initiation, and multidisciplinary rehabilitation support for the child and family

Related Conditions and Services